PC
LOXO

PointState Capital’s Loxo Oncology, Inc LOXO Stock Holding History

PointState Capital’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49,800
Closed -$3.99M – 182
2017
Q2 		$3.99M Sell
49,800
-41,800
-46% -$2.32M 0.04% 106
2017
Q1 		$3.85M Buy
+91,600
New +$3.77M 0.04% 115
2016
Q2 		– Sell
-280,000
Closed -$7.66M – 143
2016
Q1 		$7.66M Buy
+280,000
New +$5.86M 0.21% 46

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

PointState Capital's LOXO Position: Q3 2017 in Review

PointState Capital sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 49,800 shares — an estimated $3.99M sold.

PointState Capital first reported a position in LOXO in Q1 2016 and held it in 3 quarters. The position peaked at $7.66M in Q1 2016. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

  • PointState Capital reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
  • PointState Capital sold 49,800 Loxo Oncology, Inc shares in Q3 2017, an estimated $3.99M.
  • PointState Capital first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 3 quarters.
  • PointState Capital's Loxo Oncology, Inc position peaked at $7.66M in Q1 2016.
  • 148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on PointState Capital's 13F filing for Q3 2017, filed 14 Nov 2017.